IL109235A0 - Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases - Google Patents

Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases

Info

Publication number
IL109235A0
IL109235A0 IL10923594A IL10923594A IL109235A0 IL 109235 A0 IL109235 A0 IL 109235A0 IL 10923594 A IL10923594 A IL 10923594A IL 10923594 A IL10923594 A IL 10923594A IL 109235 A0 IL109235 A0 IL 109235A0
Authority
IL
Israel
Prior art keywords
lentivirus
treatment
pharmaceutical compositions
compositions containing
induced diseases
Prior art date
Application number
IL10923594A
Other versions
IL109235A (en
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of IL109235A0 publication Critical patent/IL109235A0/en
Publication of IL109235A publication Critical patent/IL109235A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
IL10923594A 1993-04-16 1994-04-06 Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus induced diseases IL109235A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939307948A GB9307948D0 (en) 1993-04-16 1993-04-16 Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease

Publications (2)

Publication Number Publication Date
IL109235A0 true IL109235A0 (en) 1994-07-31
IL109235A IL109235A (en) 1998-09-24

Family

ID=10733998

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10923594A IL109235A (en) 1993-04-16 1994-04-06 Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus induced diseases

Country Status (15)

Country Link
EP (1) EP0646004A1 (en)
JP (1) JPH07508044A (en)
KR (1) KR950701812A (en)
AU (1) AU670194B2 (en)
CA (1) CA2137148A1 (en)
CZ (1) CZ282988B6 (en)
GB (1) GB9307948D0 (en)
HU (1) HU216834B (en)
IL (1) IL109235A (en)
NO (1) NO307126B1 (en)
PL (1) PL306798A1 (en)
RU (1) RU2142798C1 (en)
TW (1) TW308593B (en)
UA (1) UA42693C2 (en)
WO (1) WO1994023718A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9504065D0 (en) * 1995-03-01 1995-04-19 Pharmacia Spa Poly-pyrrolecarboxamidonaphthalenic acid derivatives
GB9602721D0 (en) * 1996-02-09 1996-04-10 Pharmacia Spa Biologically active ureido derivatives useful in the treatment of multiple sclerosis
GB2310207A (en) * 1996-02-15 1997-08-20 Pharmacia Spa Antiviral ureido derivatives of substituted heterocyclic compounds
GB9713733D0 (en) * 1997-06-27 1997-09-03 Pharmacia & Upjohn Spa Poly-branched polycarboxamido compounds
EP3381897A1 (en) 2017-03-27 2018-10-03 Leadiant Biosciences SA Derivatives of the disodium 2,2'-{carbonylbis[imino-3,1-phenylenecarbonylimino(1-methyl-1h-pyrrole-4,2-diyl)carbonylimino]}dinaphthalene-1,5-disulfonate salt and related compounds as heparanase inhibitors for the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9000644D0 (en) * 1990-01-11 1990-03-14 Erba Carlo Spa New ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds
AU1224392A (en) * 1991-02-06 1992-09-07 Synphar Laboratories, Inc. Oligopeptide antiretroviral agents

Also Published As

Publication number Publication date
PL306798A1 (en) 1995-04-18
NO307126B1 (en) 2000-02-14
CA2137148A1 (en) 1994-10-27
AU670194B2 (en) 1996-07-04
EP0646004A1 (en) 1995-04-05
CZ10795A3 (en) 1995-09-13
HUT71838A (en) 1996-02-28
UA42693C2 (en) 2001-11-15
KR950701812A (en) 1995-05-17
RU2142798C1 (en) 1999-12-20
CZ282988B6 (en) 1997-12-17
JPH07508044A (en) 1995-09-07
NO944809D0 (en) 1994-12-12
RU94046312A (en) 1996-10-20
WO1994023718A1 (en) 1994-10-27
NO944809L (en) 1994-12-12
TW308593B (en) 1997-06-21
GB9307948D0 (en) 1993-06-02
HU9500120D0 (en) 1995-03-28
HU216834B (en) 1999-09-28
AU6537194A (en) 1994-11-08
IL109235A (en) 1998-09-24

Similar Documents

Publication Publication Date Title
IL117957A0 (en) Pharmaceutical compositions for the treatment of impotence
IL105221A0 (en) Cyclohexane derivatives and pharmaceutical compositions containing them
ZA895263B (en) Pharmaceutical composition for the prevention of sexually transmitted diseases
ZA936964B (en) Pharmaceutical compositions containing derivatives of nomegestrol and their process of manufacture
IL76561A (en) Pharmaceutical compositions containing ifn-ypsilon for the treatment of rheumatic diseases
IL105406A (en) Derivatives of adipogenesis inhibitory factor processes for the preparation thereof and pharmaceutical compositions containing the same
AU7812794A (en) Pharmaceutical compositions containing n-acetylcarnosine for the treatment of cataract
HUP9901303A3 (en) A pharmaceutical composition for the treatment of autoimmune diseases
IL104409A0 (en) Pharmaceutical compositions containing pyridobenzodiazepinones for axial myopia therapy
HUP9901247A3 (en) Use of naphthimidazole-, naphthoxazole- and naphthothiazole-diones for the preparation of pharmaceutical compositions treating diseases caused by vascular function deficiency
IL109235A0 (en) Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases
IL104132A0 (en) Compositions for the treatment of mammalian diseases
IL111144A0 (en) Pharmaceutical compositions containing amiodarone for the treatment of heart failure
IL106751A0 (en) Pharmaceutical compositions for the treatment of reversible obstructive airways diseases
HRP940315A2 (en) Process for the preparation of pharmaceutical compositions containinbg active ingredient
HUP9602324A3 (en) Piperidinyl-methyl-oxazolidinon derivatives, pharmaceutical compositions containing the same, process for the preparation of the compounds and use of them
AU6527390A (en) Pharmaceutical compositions for the treatment of ataxy and equilibrium problems
IL99666A0 (en) Pharmaceutical compositions for the treatment of diabetes
HU9302821D0 (en) Pharmaceutical compositions containing 3-substituted-2-oxindole-1-carboxamide as medical agent
GB9304745D0 (en) Use of pharmaceutical formulations
IL105690A0 (en) Pharmaceutical compositions for the treatment of arrhythmia
IL96455A0 (en) Pharmaceutical compositions for the treatment of hsv
HU9402237D0 (en) Use of benzene-sulfonyl-indol derivatives for producing pharmaceutical compositions
HUP9801985A3 (en) Use of cystine derivatives for the preparation of pharmaceutical compositions useful for the treatment of restenosis
AP9000180A0 (en) Pharmaceutical composition for the treatment of protozoal diseases

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
RH Patent void
MM9K Patent not in force due to non-payment of renewal fees